Edition:
United Kingdom

Teva Announces Launch Of A Generic Version Of Vesicare Tablets In U.S.


Monday, 22 Apr 2019 

April 22 (Reuters) - Teva Pharmaceutical Industries Ltd ::TEVA ANNOUNCES LAUNCH OF A GENERIC VERSION OF VESICARE® (SOLIFENACIN SUCCINATE) TABLETS IN THE UNITED STATES.TEVA PHARMACEUTICAL INDUSTRIES LTD - ANNOUNCED LAUNCH OF A GENERIC VERSION OF VESICARE (SOLIFENACIN SUCCINATE) TABLETS, 5 MG AND 10 MG, IN U.S..